Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.
Eleonora SeeligBeckey TrinhHenner HanssenArno Schmid-TrucksässHelga EllingsgaardMirjam Christ-CrainMarc Y DonathPublished in: Endocrinology, diabetes & metabolism (2019)
The combination of exercise and sitagliptin had no effect on beta-cell function in individuals with long-lasting type 1 DM.